Cargando…
Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global health care emergency. Anti-SARS-CoV-2 serological profiling of critically ill COVID-19 patients was performed to determine their humoral response. Blood was collected from critically ill ICU patients, either COVID-19 positive (+...
Autores principales: | Fraser, Douglas D., Cepinskas, Gediminas, Slessarev, Marat, Martin, Claudio M., Daley, Mark, Patel, Maitray A., Miller, Michael R., Patterson, Eric K., O’Gorman, David B., Gill, Sean E., Higgins, Ian, John, Julius P. P., Melo, Christopher, Nini, Lylia, Wang, Xiaoqin, Zeidler, Johannes, Cruz-Aguado, Jorge A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830473/ https://www.ncbi.nlm.nih.gov/pubmed/35366258 http://dx.doi.org/10.3390/pathophysiology28020014 |
Ejemplares similares
-
Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021) -
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)